News
When tested in a mouse model of breast cancer, the doxorubicin-loaded nanoparticles caused fewer side effects than free doxorubicin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback